Cost-Effectiveness of Gefitinib (ZD1839) compared to Additional Direct Mouth Anticoagulants and also Warfarin within the Prevention of Thromboembolic Complications Between Finnish Individuals along with Non-Valvular Atrial Fibrillation | #selinexor #niraparib #gefitinib (ZD1839)